Cancer victims urge court to end J&J bankruptcy roadblock to lawsuits

Cancer victims urge court to end J&J bankruptcy roadblock to lawsuits

Register now for FREE unlimited access to Reuters.com Register Sept 19 (Reuters) – People suing Johnson & Johnson over the company’s talc products urged an appeals court on Monday to revive their claims, saying the profitable company should not be allowed to use a bankrupt subsidiary to block lawsuits alleging the products cause cancer. They … Read more

Biden touts ‘Cancer Moonshot’ on JFK speech anniversary in Boston

Biden touts ‘Cancer Moonshot’ on JFK speech anniversary in Boston

Register now for FREE unlimited access to Reuters.com Register BOSTON, Sept 12 (Reuters) – President Joe Biden signed orders on Monday to push more government dollars to the U.S. biotechnology industry, as he promoted his initiative to create new treatments and cut the death rate from cancer. Cancer “doesn’t care if you’re Republican or Democrat,” … Read more

Wall Street looks to extend its winning streak ahead of CPI report

Wall Street looks to extend its winning streak ahead of CPI report

Register now for FREE unlimited access to Reuters.com Register Headline CPI seen easing Tuesday Bristol Myers rises on FDA approval for psoriasis drug Twitter says Musk’s latest attempt to scrap deal invalid Indexes up: Dow 0.66%, S&P 0.97%, Nasdaq 1.14% NEW YORK, Sept 12 (Reuters) – Wall Street advanced to two-week highs on Monday with … Read more

CanSino’s inhaled COVID-19 vaccine gets emergency use approval in China

CanSino’s inhaled COVID-19 vaccine gets emergency use approval in China

A logo of China’s vaccine specialist CanSino Biologics Inc is pictured on the company’s headquarters in Tianjin, following an outbreak of the coronavirus disease (COVID-19), China August 17, 2020. REUTERS/Thomas Peter//File Photo Register now for FREE unlimited access to Reuters.com Register HONG KONG, Sept 4 (Reuters) – China’s CanSino Biologics Inc (6185.HK) said on Sunday … Read more

Bayer to pay $40 million to resolve U.S. whistleblower claims over three drugs

Bayer to pay  million to resolve U.S. whistleblower claims over three drugs

The logo of Bayer AG is pictured on the facade of the historical headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay Register now for FREE unlimited access to Reuters.com Register Sept 2 (Reuters) – Bayer AG (BAYGn.DE) agreed to pay $40 million to settle claims over its … Read more

Musk sends fresh letter to scrap Twitter deal after whistleblower claims

Musk sends fresh letter to scrap Twitter deal after whistleblower claims

Register now for FREE unlimited access to Reuters.com Register Aug 30 (Reuters) – Elon Musk has sent an additional letter of deal termination to Twitter Inc (TWTR.N) to include a recent whistleblower complaint from former security head of the social media firm as another reason to scrap the $44 billion deal. Last week, Peiter Zatko, … Read more

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

Moderna’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Aug 26 (Reuters) – Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved … Read more

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval

Bluebird’s .8 million gene therapy becomes most expensive drug after U.S. approval

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved bluebird bio’s (BLUE.O) gene therapy for patients with a rare … Read more

UK first to approve Omicron COVID shot with Moderna nod

UK first to approve Omicron COVID shot with Moderna nod

A nurse prepares a dose of the Moderna coronavirus disease (COVID-19) vaccine at the Glangwili General Hospital in Carmarthen, Wales, Britain April 7, 2021. Jacob King/Pool via REUTERS Register now for FREE unlimited access to Reuters.com Register UK’s JCVI backs using bivalent shot in autumn booster campaign Moderna sees Australia, Canada, EU approvals soon LONDON, … Read more

Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln deal

Flush with cash, Pfizer buys Global Blood Therapeutics in .4 bln deal

Aug 8 (Reuters) – Pfizer Inc on Monday agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics (GBT.O), as it looks to capitalize on a surge in revenue from its COVID-19 vaccine and treatment. Pfizer will pay $68.50 per GBT share, which represents a 7.3% premium to its Friday … Read more